EU advisers recommend an oral add-on for adults who remain symptomatic on antihistamines and expanded dupilumab to ages 2-11, bringing the first biologic option to this group.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/two-new-options-chronic-spontaneous-urticaria-eu-2026a100068g?src=rss
Author :
Publish date : 2026-02-27 15:56:00
Copyright for syndicated content belongs to the linked Source.
